Your browser doesn't support javascript.
loading
Factors associated with resistance to benzodiazepines in status epilepticus.
Llauradó, Arnau; Quintana, Manuel; Ballvé, Alejandro; Campos, Daniel; Fonseca, Elena; Abraira, Laura; Toledo, Manuel; Santamarina, Estevo.
Afiliação
  • Llauradó A; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Quintana M; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Ballvé A; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Campos D; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Fonseca E; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Abraira L; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Toledo M; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain.
  • Santamarina E; Epilepsy Unit, Neurology Department, Vall de Hebron University Hospital, Barcelona, Spain. Electronic address: esantama@vhebron.net.
J Neurol Sci ; 423: 117368, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33652289
ABSTRACT

OBJECTIVE:

To investigate factors related to benzodiazepine (BZD) resistance in status epilepticus (SE) with a focus on their relationship with the etiology of the episode.

METHODS:

All SE cases in patients aged >16 years treated with BZDs were prospectively collected in our center from February 2011 to April 2019. The registry included demographics, SE type and etiology, the timing and duration of BZD administration, and the outcome. In total, 371 episodes were analyzed.

RESULTS:

Median age at SE onset was 61.3 years; the most frequent etiology was acute symptomatic (55.8%). SE with prominent motor symptoms occurred in 63.3%. Median time to BZD administration was 2 h. We studied the correlation between two-time variables time from SE onset to BZD administration and time from BZD administration to resolution of SE (response); we observed that timely administration correlated with a faster response in patients with prominent motor symptoms (p = 0.017), SE due to a chronic structural cerebral lesion (p = 0.004), and patients with a history of seizures (p = 0.013). In these subgroups (prominent motor symptoms or chronic structural lesion) BZD administration within the first 4.5 h was highly associated with shorter post-BZD SE duration (p < 0.001).

SIGNIFICANCE:

The relationship between prompt BZD administration and subsequent duration of SE was found to depend to some extent on the etiology of the episode patients with chronic structural lesions and those with previous epilepsy responded faster to BZDs. Semiology may have also its impact, as the presence of prominent motor symptoms showed also a faster response.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Epilepsia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Epilepsia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article